Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antibiotics for acute bacterial conjunctivitis.

A Sheikh1, B Hurwitz, J Cave

  • 1Department of General Practice and Primary Health Care, Imperial College School of Medicine at St. Mary's, Norfolk Place, London, UK, W2 1PG. aziz.sheikh@ic.ac.uk

The Cochrane Database of Systematic Reviews
|May 5, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Periodontitis Leads to Systemic Bone Loss through Neutrophil Reprogramming.

Journal of dental research·2025
Same author

Artificial gravity protects bone and prevents bone marrow adipose tissue accumulation in humans during 60 d of bed rest.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2025
Same author

Effectiveness of non-pharmaceutical interventions as implemented in the UK during the COVID-19 pandemic: a rapid review.

Journal of public health (Oxford, England)·2025
Same author

Allergic Rhinitis and its Impact on Asthma (ARIA) Classes in MASK-air Users.

Journal of investigational allergology & clinical immunology·2025
Same author

Comparing Interfractional Stability of Heart Dose Among Three Breath-Hold Radiotherapy Techniques in Breast Cancer.

Clinical oncology (Royal College of Radiologists (Great Britain))·2024
Same author

A clinico-radiological review of chronic non-bacterial osteomyelitis in paediatrics, adolescents, and adults: demystifying a forgotten differential.

Clinical radiology·2023

Antibiotic therapy for acute bacterial conjunctivitis significantly improves clinical and microbiological remission rates. However, this common eye infection is often self-limiting, and results from specialist care may not apply to primary care settings.

Area of Science:

  • Ophthalmology
  • Infectious Diseases
  • Evidence-Based Medicine

Background:

  • Acute bacterial conjunctivitis is a common eye infection with ongoing debate about the benefits of antibiotic treatment.
  • Concerns exist regarding the necessity and efficacy of antibiotics for this condition.

Purpose of the Study:

  • To systematically review and assess the benefits and harms of antibiotic therapy in managing acute bacterial conjunctivitis.
  • To evaluate the impact of antibiotics on clinical and microbiological outcomes.

Main Methods:

  • Conducted a systematic review of double-masked randomized controlled trials comparing antibiotic treatments with placebo.
  • Searched multiple databases including Cochrane Eyes and Vision Group, Central, and MEDLINE up to September 1998.
  • Extracted data, checked accuracy, and performed meta-analysis to summarize relative risks and test for heterogeneity.

Related Experiment Videos

Main Results:

  • Three trials met eligibility criteria; meta-analysis showed antibiotics significantly improved early clinical remission (RR 1.31) and microbiological remission rates.
  • Acute bacterial conjunctivitis is frequently self-limiting, with spontaneous clinical remission occurring in 64% of placebo-treated patients by days 2-5.
  • No serious sight-threatening complications were reported in either antibiotic or placebo groups.

Conclusions:

  • Antibiotic use is associated with significantly improved early clinical and microbiological remission in acute bacterial conjunctivitis.
  • Findings from specialist care populations may not be generalizable to primary care.
  • Further research, including a primary care-based cost-effectiveness trial, is warranted.